Table 3.
Associations between serum folate levels and clinicopathological features of gastric cancer n (%)
|
Folate |
Odds ratio1 |
|||
| > 2.61 ng/mL | ≤ 2.61 ng/mL | 95%CI | P value2 | |
| Stage | ||||
| Early (n = 28) | 14 (50.0) | 14 (50.0) | 1 | |
| Advanced (n = 127) | 54 (42.5) | 73 (57.5) | 1.38 (0.60-3.14) | NS |
| Serosal invasion | ||||
| Absent (n = 43) | 26 (60.5) | 17 (39.5) | 1 | |
| Present (n = 112) | 42 (37.5) | 70 (62.5) | 2.54 (1.23-5.23) | < 0.05 |
| Lymph node metastasis | ||||
| Absent (n = 51) | 26 (51.0) | 25 (49.0) | 1 | |
| Present (n = 104) | 42 (40.4) | 62 (59.6) | 1.54 (0.78-3.02) | NS |
| Venous invasion | ||||
| Absent (n = 90) | 42 (46.7) | 48 (53.3) | 1 | |
| Present (n = 65) | 26 (40.0) | 39 (60.0) | 1.32 (0.69-2.52) | NS |
| Lymphatic invasion | ||||
| Absent (n = 74) | 40 (54.1) | 34 (45.9) | 1 | |
| Present (n = 81) | 28 (34.6) | 53 (65.4) | 2.23 (1.17-4.26) | < 0.05 |
| Liver metastasis | (> 1.9 ng/mL) | (≤ 1.90 ng/mL) | ||
| Absent (n = 146) | 104 (71.2) | 42 (28.8) | 1 | |
| Present (n = 8) | 2 (25.0) | 6 (75.0) | 6.67 (1.28-34.91) | <0.05 |
1
Age and gender were adjusted by multivariate regression analysis;
2
All P values ≥ 0.05 were considered to be statistically non-significant (NS).